the efficacy of antiviral hepatitis therapy on psychiatric symptoms in psychiatric disorders complicated by viral hepatitis.

the efficacy of antiviral hepatitis therapy on psychiatric symptoms in psychiatric disorders complicated by viral hepatitis. - the efficacy of antiviral hepatitis therapy on psychiatric symptoms.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000059289

Enrollment

100

Registered

2025-11-01

Start date

2025-08-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression, schizophrenia, bipolar disorder, dementia with HCV or HBV infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Outpatients or inpatients diagnosed with depression, schizophrenia, bipolar disorder, or dementia, who have infection with HCV or HBV, who meet the indication for antiviral therapy, and who wish to receive it. Those who, after sufficient explanation and full understanding, give their written consent voluntarily.

Exclusion criteria

Exclusion criteria: Those for whom it is judged difficult to assess psychiatric symptoms before and after antiviral therapy. Those whom the principal investigator deems inappropriate as subjects.

Design outcomes

Primary

Measure	Time frame
Psychiatric symptoms are assessed within one month before the beginning of the anti-viral therapy and 3 months after. depression: MADRS, HADS-A or HADS-D, schizophrenia: SOFA or SCGI-SCH, bipolar disorder: YMRS, dementia: MMSE	—

Countries

Japan

Contacts

Public ContactYoshimichi Haruna

Osaka Psychiatric Medical Center Department of Medical Affairs

apple-123-grape@ab.auone-net.jp0728473261

Outcome results